Timothy M. Mitchell

Lab Pathways, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area. In 2010, CeeTox purchased certain assets formerly owned by ADMETRx Inc. This asset purchase increases CeeTox's existing ADME capabilities and is yet another step in its strategy to expand its range of in vitro service offerings. The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process.

DCL Medical Laboratories, established in 1984, is a full service regional laboratory that researches, markets and performs anatomic, clinical and molecular pathology testing for medical diagnostic applications. DCL also provides anatomic and molecular pathology services for global clinical trials in partnership with the world's largest central laboratories and clinical research organizations.

ACM Medical Laboratory, Inc. provides medical laboratory testing and diagnostic lab services. It offers physician services, anatomic pathology, women's health, drug testing, and information technology services. The company was founded in 1997 and is headquartered in Rochester, NY.

Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.